Latest JOHNSON & JOHNSON Stock Portfolio
JOHNSON & JOHNSON Performance:
2024 Q3: 4.54%YTD: -5.81%2023: 15.2%
Performance for 2024 Q3 is 4.54%, and YTD is -5.81%, and 2023 is 15.2%.
About JOHNSON & JOHNSON and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, JOHNSON & JOHNSON reported an equity portfolio of $427.3 Millions as of 30 Sep, 2024.
The top stock holdings of JOHNSON & JOHNSON are PTGX, , . The fund has invested 25.8% of it's portfolio in PROTAGONIST THERAPEUTICS INC. and 12% of portfolio in RAPPORT THERAPEUTICS, INC.
The fund managers got completely rid off ALDEYRA THERAPEUTICS, INC. (ALDX) stocks. They significantly reduced their stock positions in BIOMX INC. (PHGE). JOHNSON & JOHNSON opened new stock positions in CLEARSIDE BIOMEDICAL, INC. (CLSD).
The top stock holdings of JOHNSON & JOHNSON are PTGX, , . The fund has invested 25.8% of it's portfolio in PROTAGONIST THERAPEUTICS INC. and 12% of portfolio in RAPPORT THERAPEUTICS, INC.
The fund managers got completely rid off ALDEYRA THERAPEUTICS, INC. (ALDX) stocks. They significantly reduced their stock positions in BIOMX INC. (PHGE). JOHNSON & JOHNSON opened new stock positions in CLEARSIDE BIOMEDICAL, INC. (CLSD).
JOHNSON & JOHNSON Annual Return Estimates Vs S&P 500
Our best estimate is that JOHNSON & JOHNSON made a return of 4.54% in the last quarter. In trailing 12 months, it's portfolio return was 33.09%.
New Buys
| Ticker | $ Bought |
|---|---|
| clearside biomedical, inc. | 104,751 |
New stocks bought by JOHNSON & JOHNSON
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| biomx inc. | -90.00 |
JOHNSON & JOHNSON reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| aldeyra therapeutics, inc. | -991,904 |
JOHNSON & JOHNSON got rid off the above stocks
Sector Distribution
JOHNSON & JOHNSON has about 56.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 56.4 |
| Others | 43.6 |
Market Cap. Distribution
JOHNSON & JOHNSON has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 43.6 |
| MID-CAP | 33.6 |
| SMALL-CAP | 12.9 |
| MICRO-CAP | 9.8 |
Stocks belong to which Index?
About 56.4% of the stocks held by JOHNSON & JOHNSON either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 56.4 |
| Others | 43.6 |
JOHNSON & JOHNSON Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of JOHNSON & JOHNSON
JOHNSON & JOHNSON has 20 stocks in it's portfolio. About 94.4% of the portfolio is in top 10 stocks. CVRX proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for JOHNSON & JOHNSON last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio, inc. | 0.12 | 364,472 | 524,840 | unchanged | 0.00 | ||
| ALDX | aldeyra therapeutics, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARWR | arrowhead pharmaceuticals, inc. | 1.12 | 247,598 | 4,795,970 | unchanged | 0.00 | ||
| CLSD | clearside biomedical, inc. | 0.03 | 82,481 | 104,751 | new | |||
| CVRX | cvrx, inc. | 8.46 | 4,103,430 | 36,151,200 | unchanged | 0.00 | ||
| FATE | fate therapeutics, inc. | 2.77 | 3,379,060 | 11,826,700 | unchanged | 0.00 | ||
| LAB | standard biotools inc | 0.14 | 311,967 | 602,096 | unchanged | 0.00 | ||
| MGTX | meiragtx holdings plc | 6.48 | 6,641,060 | 27,693,200 | unchanged | 0.00 | ||
| NBTX | nanobiotix s.a. | 7.57 | 5,623,820 | 32,336,900 | unchanged | 0.00 | ||
| NNOX | nano-x imaging ltd. | 0.23 | 158,852 | 965,820 | unchanged | 0.00 | ||
| PHGE | biomx inc. | 0.05 | 192,321 | 196,167 | reduced | -90.00 | ||
| PRCT | procept biorobotics corporation | 6.71 | 357,939 | 28,678,100 | unchanged | 0.00 | ||
| PTGX | protagonist therapeutics inc. | 25.79 | 2,449,180 | 110,213,000 | unchanged | 0.00 | ||
| RLYB | rallybio corporation | 1.00 | 3,636,360 | 4,254,540 | unchanged | 0.00 | ||
| SENS | senseonics holdings, inc. | 0.00 | 54,621 | 19,101 | unchanged | 0.00 | ||
| VOR | vor biopharma, inc. | 0.18 | 1,074,660 | 752,261 | unchanged | 0.00 | ||
| XNCR | xencor, inc. | 3.52 | 748,062 | 15,043,500 | unchanged | 0.00 | ||
| rapport therapeutics, inc. | 11.97 | 2,498,050 | 51,160,100 | unchanged | 0.00 | |||
| legend biotech corporation | 9.29 | 814,586 | 39,694,800 | unchanged | 0.00 | |||
| contineum therapeutics inc. | 8.87 | 1,979,170 | 37,881,400 | unchanged | 0.00 | |||